SGLT2 inhibitorsfor treatment of chronic kidney disease without diabetes or heart failure

Autor:	Feldt-Rasmussen, Bo, Borg, Rikke, Carstens, Jan, Hansen, Ditte, Hornum, Mads, Lindhardt, Morten, Mose, Frank Holden, Bang Pedersen, Birgitte, Povlsen, Johan, Dyhr Schandorff, Kristine, Strandhave, Charlotte
Jazyk:	dánština
Rok vydání:	2022
Předmět:	Male Sodium-Glucose Transporter 2 Renal Insufficiency Chronic/complications Diabetes Mellitus Humans Female Electroconvulsive Therapy/adverse effects Heart Failure/drug therapy
Zdroj:	Feldt-Rasmussen, B, Borg, R, Carstens, J, Hansen, D, Hornum, M, Lindhardt, M, Mose, F H, Pedersen, B B, Poulsen, J V, Schandorff, K D & Strandhave, C 2022, ' SGLT2-hæmning til kronisk nyresygdom uden ledsagende diabetes eller hjertesvigt ', Ugeskift for Læger, bind 184, nr. 20, V11210887, s. 1872-1875 . < https://ugeskriftet.dk/videnskab/sglt2-haemning-til-kronisk-nyresygdom-uden-ledsagende-diabetes-eller-hjertesvigt > Feldt-Rasmussen, B, Borg, R, Carstens, J, Hansen, D, Hornum, M, Lindhardt, M, Mose, F H, Pedersen, B B, Poulsen, J V, Schandorff, K D & Strandhave, C 2022, ' SGLT2-hæmning til kronisk nyresygdom uden ledsagende diabetes eller hjertesvigt ', Ugeskrift for Laeger, bind 184, nr. 16, V11210887 . < https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-04/v11210887_web.pdf > Feldt-Rasmussen, B, Borg, R, Carstens, J, Hansen, D, Hornum, M, Lindhardt, M, Mose, F H, Bang Pedersen, B, Povlsen, J, Dyhr Schandorff, K & Strandhave, C 2022, ' SGLT2-hæmning til kronisk nyresygdom uden ledsagende diabetes eller hjertesvigt ', Ugeskrift for Læger, bind 184, V11210887 . < https://ugeskriftet.dk/videnskab/sglt2-haemning-til-kronisk-nyresygdom-uden-ledsagende-diabetes-eller-hjertesvigt?time=1650374163&utm_campaign=&utm_medium=Ugentlig&utm_source=Newsletter >
Popis:	This review summarises the current knowledge of electroconvulsive therapy (ECT) which is still the most potent and fast-acting antidepressant intervention. The modern procedure is safe when general precautions are taken. Cognitive side effects are transient in most patients, and concerns about side effects should not prevent relevant use. Due to the prognostic benefits of rapid remission, ECT should, in relevant patients, be considered early in the treatment course. Patients should be offered maintenance pharmacotherapy, and, in high-risk cases, tapering of the acute ECT course or maintenance ECT, in order to reduce the risk of relapse.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::471d5bc158004a5a078e32ad2c448668 https://vbn.aau.dk/da/publications/54d666b4-45e7-4f88-ad5e-b53e24ec371a Zobrazit plný text záznamu